Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.oftal.2012.12.013 | DOI Listing |
Sci Rep
September 2024
Department of Ophthalmology, Kanazawa University Graduate School of Medical Sciences, 13-1 Takara-Machi, Kanazawa, Ishikawa, 920-8641, Japan.
Clin Ophthalmol
July 2024
Department of Ophthalmology, Seoul National University, Seoul, Republic of Korea.
Purpose: To compare the efficacy and safety of omidenepag isopropyl (OMDI) 0.002% with latanoprost 0.005% once daily in Asian subjects with open-angle glaucoma (OAG)/ocular hypertension (OHT).
View Article and Find Full Text PDFBioengineering (Basel)
January 2024
Roski Eye Institute, Keck School of Medicine, University of Southern California, 1450 San Pablo Street, Los Angeles, CA 90033, USA.
Glaucoma is a leading cause of irreversible blindness, and early detection and treatment are crucial for preventing vision loss. This review aims to provide an overview of current diagnostic and treatment standards, recent medical and technological advances, and current challenges and future outlook for wearable glaucoma diagnostics and therapeutics. Conventional diagnostic techniques, including the rebound tonometer and Goldmann Applanation Tonometer, provide reliable intraocular pressure (IOP) measurement data at single-interval visits.
View Article and Find Full Text PDFInvest Ophthalmol Vis Sci
March 2023
CHU Bordeaux, Department of Ophthalmology, Bordeaux, France.
Purpose: The purpose of this study was to compare 24-hour intraocular pressure (IOP) related fluctuations monitoring between 2 groups of visual field progression rates in patients with open angle glaucoma (OAG).
Methods: Cross-sectional study performed at Bordeaux University Hospital. Twenty-four-hour monitoring was performed using a contact lens sensor (CLS; Triggerfish; SENSIMED, Etagnières, Switzerland).
J Clin Med
August 2022
Glaucoma Research Center, Montchoisi Clinic, Swiss Visio, 1006 Lausanne, Switzerland.
Background: The purpose of this study is to evaluate the outcome of deep sclerectomy (DS) as a secondary procedure following failed ab-interno XEN gel stent implantation in patients with open-angle glaucoma. Methods: Prospective, single-center, non-randomized, interventional study. Consecutive eyes that underwent mitomycin C (MMC) augmented XEN gel stent surgery, with uncontrolled intraocular pressure (IOP) or signs of disease progression, were included to undergo MMC-augmented DS.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!